Company intelligence
Ozack ApS
Regulatory Consultancy and Strategy
About Ozack ApS
Entrepreneurs that move from research to clinical development phases and beyond go into a very regulated area with options as well as pitfalls. Chances of success are increased significantly if a company is aware of all this and more good medicines will reach the patients that way. Ozack wants to increase progress by infusing our knowledge to navigate the regulatory maze through development of medicine within all phases of drug development. We will • work out regulatory strategies with the company to choose the best route and mitigate risk • glue clinical, nonclinical, and CMC data together into a well understood story • ensure successful liaising with Health Authorities as partners rather than opponents
Verified activity
Signals from Ozack ApS
3 published signals
Presence & Recognition
Ozack ApS participated in a symposium hosted by Labcorp Preclinical & Nonclinical covering Precision, Prediction, and the 3Rs at the Waters of Prioritizing NAMs to reduce use of animals in drug development.
Reported by Ozack ApS
Presence & Recognition
Ozack ApS is hosting an evening on the 30th of September at 14:30 at Symbion Community at Frederiksberg for an evening marking 10 years of Ozack
Reported by Ozack ApS
Presence & Recognition
Ozack ApS attended a meeting featuring presentations, panel discussions, and reflections by Jesper J. Lange.
Reported by Ozack ApS